Experimental melanoma vaccine shows promising results
An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients. It's personalized for each patient and optimized using artificial intelligence. Dr.
Jon LaPook has more details.
💡 AI analysis provides alternative perspectives on current events